Status:

UNKNOWN

The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota

Lead Sponsor:

Chinese University of Hong Kong

Collaborating Sponsors:

University of Melbourne

The University of Queensland

Conditions:

Crohn Disease

Eligibility:

All Genders

18+ years

Brief Summary

The incidence of inflammatory bowel diseases, (IBD) including Crohn's disease (CD) and ulcerative colitis (UC), is increasing in the developing world. Our recent Asia-Pacific population-based study in...

Detailed Description

The incidence of inflammatory bowel diseases, (IBD) including Crohn's disease (CD) and ulcerative colitis (UC), is increasing in the developing world. Our recent Asia-Pacific population-based study in...

Eligibility Criteria

Inclusion

  • aged ≥18 years old
  • competent to provide informed consent (no mental illness or dementia, etc. that will hinder the understanding)
  • living in the same area for recent 6 months

Exclusion

  • Use of anticoagulants within 1 week
  • Use of prebiotics, probiotics or antibiotics in recent 3 months
  • Use of laxatives or "Stoppers" in the last 3 months
  • Vaccination within 3 months
  • Recent dietary changes (e.g. becoming vegetarian/vegan)
  • Known complex infections or sepsis (excl. simple infections such as influenza etc.)
  • Known history or concomitant significant food allergies
  • Known history of severe organ failure (including decompensated cirrhosis, malignant disease, kidney failure, epilepsy, active serious infection, acquired immunodeficiency syndrome)
  • Bowel surgery in the last 6 months (excluding colonoscopy/ procedure related to perianal disease)
  • Having stoma
  • Known pregnancy
  • Travel history within 4 weeks (need to define the travel history in China)
  • Known contraindications to colonoscopy
  • Colonoscopy in the last month prior to sampling

Key Trial Info

Start Date :

August 29 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 28 2024

Estimated Enrollment :

532 Patients enrolled

Trial Details

Trial ID

NCT03462875

Start Date

August 29 2018

End Date

February 28 2024

Last Update

February 8 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prince of Wales Hospital

Hong Kong, Hong Kong